Log in to search using one of your social media accounts:

 

Ixazomib in the management of relapsed multiple myeloma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 22, 2018 Category: Cancer & Oncology Authors: Cyrille Touzeau Philippe Moreau Source Type: research

CLL2-BXX Phase II trials: sequential, targeted treatment for eradication of minimal residual disease in chronic lymphocytic leukemia
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 21, 2018 Category: Cancer & Oncology Authors: Paula Cramer Julia von Tresckow Jasmin Bahlo Anja Engelke Petra Langerbeins Anna-Maria Fink Kirsten Fischer Clemens-Martin Wendtner Karl-Anton Kreuzer Stephan Stilgenbauer Sebastian B öttcher Barbara Eichhorst Michael Hallek Source Type: research

Pembrolizumab and its use in the treatment of recurrent or metastatic head and neck cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 21, 2018 Category: Cancer & Oncology Authors: Siddharth Sheth Jared Weiss Source Type: research

Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 20, 2018 Category: Cancer & Oncology Authors: Thomas T DeLeon Daniel H Ahn James M Bogenberger Panos Z Anastasiadis Mansi Arora Ramesh K Ramanathan Bashar A Aqel George Vasmatzis Mark J Truty Rahmi Oklu Tanios S Bekaii-Saab Mitesh J Borad Source Type: research

Nivolumab in the treatment of advanced renal cell carcinoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 20, 2018 Category: Cancer & Oncology Authors: Malmaruha Arasaratnam Howard Gurney Source Type: research

The brigatinib experience: a new generation of therapy for ALK-positive non-small-cell lung cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 16, 2018 Category: Cancer & Oncology Authors: Idoroenyi Amanam Rohan Gupta Isa Mambetsariev Ravi Salgia Source Type: research

Understanding the nuances of microwave ablation for more accurate post-treatment assessment
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 14, 2018 Category: Cancer & Oncology Authors: Christy Kim Source Type: research

Imaging after radiofrequency ablation of renal tumors
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 14, 2018 Category: Cancer & Oncology Authors: Umberto Russo Umberto Maestroni Roberto Vito Papapietro Vincenzo Trunfio Francesco Ziglioli Stefania Ferretti Luca Brunese Gianpaolo Carrafiello Massimo De Filippo Source Type: research

Erratum
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 14, 2018 Category: Cancer & Oncology Source Type: research

Understanding the nuances of microwave ablation for more accurate post-treatment assessment
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 14, 2018 Category: Cancer & Oncology Authors: Christy Kim Source Type: research

Imaging after radiofrequency ablation of renal tumors
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 14, 2018 Category: Cancer & Oncology Authors: Umberto Russo Umberto Maestroni Roberto Vito Papapietro Vincenzo Trunfio Francesco Ziglioli Stefania Ferretti Luca Brunese Gianpaolo Carrafiello Massimo De Filippo Source Type: research

Erratum
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 14, 2018 Category: Cancer & Oncology Source Type: research

Computed tomography densitometric study of anti-angiogenic effect of regorafenib in colorectal cancer liver metastasis
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 13, 2018 Category: Cancer & Oncology Authors: Alfonso Reginelli Alfredo Clemente Claudia Cardone Fabrizio Urraro Andrea Izzo Erika Martinelli Teresa Troiani Fortunato Ciardiello Luca Brunese Salvatore Cappabianca Source Type: research

Hydration requirements with emetogenic chemotherapy: granisetron extended-release subcutaneous versus palonosetron
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 9, 2018 Category: Cancer & Oncology Authors: Jeffrey Vacirca Dennis Caruana George Calcanes Michael Mosier Ralph Boccia Ali McBride Source Type: research

The challenges of fertility preservation in cancer patients: an interview with Michael Grynberg
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 9, 2018 Category: Cancer & Oncology Authors: Michael Grynberg Source Type: research

A multiparametric analysis combining DCE-MRI- and IVIM -derived parameters to improve differentiation of parotid tumors: a pilot study
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 9, 2018 Category: Cancer & Oncology Authors: Francesca Patella Giuseppe Franceschelli Mario Petrillo Mario Sansone Roberta Fusco Filippo Pesapane Giovanni Pompili Anna Maria Ierardi Alberto Maria Saibene Laura Moneghini Federico Biglioli Gianpaolo Carrafiello Source Type: research

FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 9, 2018 Category: Cancer & Oncology Authors: Kathleen N Moore Ignace Vergote Ana Oaknin Nicoletta Colombo Susana Banerjee Amit Oza Patricia Pautier Karim Malek Michael J Birrer Source Type: research

Hydration requirements with emetogenic chemotherapy: granisetron extended-release subcutaneous versus palonosetron
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 9, 2018 Category: Cancer & Oncology Authors: Jeffrey Vacirca Dennis Caruana George Calcanes Michael Mosier Ralph Boccia Ali McBride Source Type: research

The challenges of fertility preservation in cancer patients: an interview with Michael Grynberg
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 9, 2018 Category: Cancer & Oncology Authors: Michael Grynberg Source Type: research

A multiparametric analysis combining DCE-MRI- and IVIM -derived parameters to improve differentiation of parotid tumors: a pilot study
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 9, 2018 Category: Cancer & Oncology Authors: Francesca Patella Giuseppe Franceschelli Mario Petrillo Mario Sansone Roberta Fusco Filippo Pesapane Giovanni Pompili Anna Maria Ierardi Alberto Maria Saibene Laura Moneghini Federico Biglioli Gianpaolo Carrafiello Source Type: research

FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 9, 2018 Category: Cancer & Oncology Authors: Kathleen N Moore Ignace Vergote Ana Oaknin Nicoletta Colombo Susana Banerjee Amit Oza Patricia Pautier Karim Malek Michael J Birrer Source Type: research

Lung cancer: a brief review of epidemiology and screening
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 8, 2018 Category: Cancer & Oncology Authors: Cl áudia Gouvinhas Ramon Andrade De Mello Daniela Oliveira Jos é Manuel Castro-Lopes Pedro Castelo-Branco Ricardo Sales dos Santos Venceslau Hespanhol Daniel Humberto Pozza Source Type: research

Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 8, 2018 Category: Cancer & Oncology Authors: Scott C Flanders Janet Kim Samuel Wilson Jeffrey Braziunas Sheldon Greenfield John Billimek Stanislav Lechpammer Daniel W Lin Lawrence Karsh David I Quinn Daniel Shevrin Neal D Shore James T Symanowski David F Penson Source Type: research

Lung cancer: a brief review of epidemiology and screening
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 8, 2018 Category: Cancer & Oncology Authors: Cl áudia Gouvinhas Ramon Andrade De Mello Daniela Oliveira Jos é Manuel Castro-Lopes Pedro Castelo-Branco Ricardo Sales dos Santos Venceslau Hespanhol Daniel Humberto Pozza Source Type: research

Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 8, 2018 Category: Cancer & Oncology Authors: Scott C Flanders Janet Kim Samuel Wilson Jeffrey Braziunas Sheldon Greenfield John Billimek Stanislav Lechpammer Daniel W Lin Lawrence Karsh David I Quinn Daniel Shevrin Neal D Shore James T Symanowski David F Penson Source Type: research

Why does a high-fat diet increase cancer risk?
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 7, 2018 Category: Cancer & Oncology Authors: Vanessa Benham Jamie J Bernard Source Type: research

High-fat diet and colorectal cancer: myths and facts
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 7, 2018 Category: Cancer & Oncology Authors: Sheelarani Karunanithi Liraz Levi Source Type: research

Tumor necrosis and > 20  mitoses per 50 high-power fields can distinguish ‘very high-risk’ and ‘highest-risk’ within ‘high-risk’ gastric gastrointestinal stromal tumor
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 7, 2018 Category: Cancer & Oncology Authors: Jiabin Zheng Renjie Li Haibo Qiu Tao Chen Yongjian Zhou Changming Huang Guoxin Li Zhiwei Zhou Yong Li Source Type: research

Eribulin therapy for the treatment of patients with advanced soft tissue sarcoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 7, 2018 Category: Cancer & Oncology Authors: Mahesh Seetharam Kantha R Kolla Sant P Chawla Source Type: research

Why does a high-fat diet increase cancer risk?
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 7, 2018 Category: Cancer & Oncology Authors: Vanessa Benham Jamie J Bernard Source Type: research

High-fat diet and colorectal cancer: myths and facts
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 7, 2018 Category: Cancer & Oncology Authors: Sheelarani Karunanithi Liraz Levi Source Type: research

Tumor necrosis and > 20  mitoses per 50 high-power fields can distinguish ‘very high-risk’ and ‘highest-risk’ within ‘high-risk’ gastric gastrointestinal stromal tumor
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 7, 2018 Category: Cancer & Oncology Authors: Jiabin Zheng Renjie Li Haibo Qiu Tao Chen Yongjian Zhou Changming Huang Guoxin Li Zhiwei Zhou Yong Li Source Type: research

Eribulin therapy for the treatment of patients with advanced soft tissue sarcoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 7, 2018 Category: Cancer & Oncology Authors: Mahesh Seetharam Kantha R Kolla Sant P Chawla Source Type: research

High NUP43 expression might independently predict poor overall survival in luminal A and in HER2+ breast cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 6, 2018 Category: Cancer & Oncology Authors: Chao Tian Shijie Zhou Cheng Yi Source Type: research

Subcutaneous rituximab with recombinant human hyaluronidase in the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 6, 2018 Category: Cancer & Oncology Authors: Samuel Luke Hill Andrew Davies Source Type: research

High NUP43 expression might independently predict poor overall survival in luminal A and in HER2+ breast cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 6, 2018 Category: Cancer & Oncology Authors: Chao Tian Shijie Zhou Cheng Yi Source Type: research

Subcutaneous rituximab with recombinant human hyaluronidase in the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 6, 2018 Category: Cancer & Oncology Authors: Samuel Luke Hill Andrew Davies Source Type: research

Enhanced Recovery After Surgery (ERAS ®) in thoracic surgical oncology
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 5, 2018 Category: Cancer & Oncology Authors: Alessandro Gonfiotti Domenico Viggiano Stefano Bongiolatti Luca Bertolaccini Piergiorgio Solli Alessandro Bertani Luca Voltolini Roberto Crisci Andrea Droghetti Source Type: research

Is it appropriate to perform video-assisted thoracoscopic surgery for advanced lung cancer?
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 5, 2018 Category: Cancer & Oncology Authors: David Sanchez-Lorente Rudith Guzman Marc Boada Nicole Carriel Angela Guirao Laureano Molins Source Type: research

Single-institution experience of intensity-modulated radiotherapy for malignant pleural mesothelioma at University of Catania
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 5, 2018 Category: Cancer & Oncology Authors: Corrado Spatola Carmelo Militello Alessandra Tocco Vincenzo Salamone Raffaele Luigi Marcello Migliore Dario Marletta Alessandra Cannizzaro Roberta Bevilacqua Pietro Milone Stefano Pergolizzi Giuseppe Privitera Source Type: research

Enhanced Recovery After Surgery (ERAS ®) in thoracic surgical oncology
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 5, 2018 Category: Cancer & Oncology Authors: Alessandro Gonfiotti Domenico Viggiano Stefano Bongiolatti Luca Bertolaccini Piergiorgio Solli Alessandro Bertani Luca Voltolini Roberto Crisci Andrea Droghetti Source Type: research

Is it appropriate to perform video-assisted thoracoscopic surgery for advanced lung cancer?
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 5, 2018 Category: Cancer & Oncology Authors: David Sanchez-Lorente Rudith Guzman Marc Boada Nicole Carriel Angela Guirao Laureano Molins Source Type: research

Single-institution experience of intensity-modulated radiotherapy for malignant pleural mesothelioma at University of Catania
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - February 5, 2018 Category: Cancer & Oncology Authors: Corrado Spatola Carmelo Militello Alessandra Tocco Vincenzo Salamone Raffaele Luigi Marcello Migliore Dario Marletta Alessandra Cannizzaro Roberta Bevilacqua Pietro Milone Stefano Pergolizzi Giuseppe Privitera Source Type: research

Novel applications for an established antimalarial drug: tumoricidal activity of quinacrine
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - January 30, 2018 Category: Cancer & Oncology Authors: Hongru Yan Anning Bian Xiaoge Gao Huiqin Li Zetian Chen Xiangye Liu Source Type: research

CPX-351: changing the landscape of treatment for patients with secondary acute myeloid leukemia
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - January 30, 2018 Category: Cancer & Oncology Authors: Chetasi Talati Jeffrey E Lancet Source Type: research

Novel applications for an established antimalarial drug: tumoricidal activity of quinacrine
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - January 30, 2018 Category: Cancer & Oncology Authors: Hongru Yan Anning Bian Xiaoge Gao Huiqin Li Zetian Chen Xiangye Liu Source Type: research

CPX-351: changing the landscape of treatment for patients with secondary acute myeloid leukemia
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - January 30, 2018 Category: Cancer & Oncology Authors: Chetasi Talati Jeffrey E Lancet Source Type: research

Global named patient use program of afatinib in advanced non-small-cell lung carcinoma patients who progressed following prior therapies
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - January 29, 2018 Category: Cancer & Oncology Authors: Federico Cappuzzo Ross Soo Maximilian Hochmair Martin Schuler Kwok Chi Lam Gerd Stehle Agnieszka Cseh Robert M Lorence Stephan Linden Nicole D Forman Wolfgang Hilbe Abdul Rahman Jazieh Chun-Ming Tsai Source Type: research